Author information unavailable
Abstract
The United States Food and Drug Administration (FDA) has proposed new label warnings for all nonsteroidal anti-inflammatory drugs (NSAIDs) to warn about potential cardiovascular and other toxicities associated with these medications. The proposed label requirements are presented.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The United States Food and Drug Administration (FDA) has proposed new label warnings for all nonsteroidal anti-inflammatory drugs (NSAIDs) to warn about potential cardiovascular and other toxicities associated with these medications. The proposed label requirements are presented.
Key concepts: Medicine, Package insert, Food and drug administration, Nonsteroidal, Drug labeling, Drug, Pharmacology